Rylux BSU Stimulates Spore Germination in Trichophyton mentagrophytes and Aspergillus fumigatus and Increases the Survival Rate after UV-Irradiation

Folia Microbiologica

Volumn 47, Issue 2, 2002, Pages 152-156

  Chalupova V ^a   Raclavsky V ^a   Novotny R ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRODERMA BENHAMIAE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BACTERIA (MICROORGANISMS); TRICHOPHYTON;

BENZENESULFONIC ACID DERIVATIVE; FLUORESCENT DYE; RYLUX BSU;

ARTICLE; ASPERGILLUS FUMIGATUS; CULTURE MEDIUM; DRUG EFFECT; FUNGUS SPORE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; RADIATION EXPOSURE; SCANNING ELECTRON MICROSCOPY; TRICHOPHYTON; ULTRAVIOLET RADIATION;

ASPERGILLUS FUMIGATUS; BENZENESULFONATES; CULTURE MEDIA; FLUORESCENT DYES; MICROSCOPY, ELECTRON, SCANNING; SPORES, FUNGAL; TRICHOPHYTON; ULTRAVIOLET RAYS;

EID: 0036355168     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02817673     Document Type: Article

References (30)

1. ALDEA M., CASAS C., GALLEGO C., ESPINET C., HERRERO E.: The yeast cell cycle: positive and negative controls. Microbiologia 10, 27-36 (1994).
2. CARDENAS M.E., CRUZ M.C., DEL POETA M., CHUNG N., PERFECT J.R., HEITMAN J.: Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin.Microbiol.Rev. 12, 583-611 (1999).
3. CHEN K. C., CSIKASZ-NAGY A., GYORFFY B., VAL J., NOVAK B., TYSON J.J.: Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol.Biol.Cell 11, 369-391 (2000).
4. CHUN K.T., GOEBL M.G.: The identification of transposon-tagged mutations in essential genes that affect cell morphology in Saccharomyces cerevisiae. Genetics 142, 39-50 (1996).
5. DELITHEOS A., KARAVOKYROS I., TILIGADA E. Response of Saccharomyces cerevisiae strains to antineoplastic agents. J.Appl.Bacteriol. 79, 379-383 (1995a).
6. DELITHEOS A., TILIGADA E., STAVRINIDIS E., MANOLIS C., VOVOU I.: Effect of antineoplastic drugs on Saccharomyces crevisiae under stress conditions. Anticanc.Res. 15, 2921 (1995b).
7. GIMENO C.J., LJUNGDAHL P.O., STYLES C.A., FINK G.R.: Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: regulation by starvation and RAS. Cell 68, 1077-1090 (1992).
8. HARTWELL L.H.: Role of yeast in cancer research. Cancer 69, 2615-2621 (1992).
9. HARTWELL L.H.: Macromolecule synthesis in temperature-sensitive mutants of yeast. J.Bacteriol. 93, 1662-1670 (1967).
10. HERSKOWITZ I.: Life cycle of the budding yeast Saccharomyces cerevisiae. Microbiol.Rev. 52, 536-553 (1988).
11. LEE S.S., ROBINSON S.M., WANG H.Y.: Rapid determination of yeast viability. Biotech.Bioengin.Symp. 11, 641-649 (1981).
12. LEW D.J., REED S.I.: Cell cycle control of morphogenesis in budding yeast. Curr.Opin.Genet.Dev. 5, 17-23 (1995).
13. LIM S.T., JUE C.K., MOORE C.W., LIPKE P.M.: Oxidative cell wall damage mediated by bleomycin-Fe(II) in Saccharomyces cerevisiae. J. Bacteriol. 177, 3534-3539 (1995).
14. MENDOZA I., QUINTERO F.J., BRESSAN R.A., HASEGAWA P.M., PARDO J.M.,: Activated calcineurin confers high tolerance to ion stress and alters the budding pattern and cell morphology of yeast cells. J.Biol.Chem. 271, 23061-23067 (1996).
15. MILIGKOS V., TILIGADA E., PAPAMICHAEL K., YPSILANTIS E., DELITHEOS A.: Anticancer drugs as inducers of thermotolerance in yeast. Folia Microbiol. 45, 339-342 (2000).
16. MOORE C.W., DEL VALLE R., MCKOY J., PRAMANIK A., GORDON R.E.: Lesions and preferential initial localization of (S-methyl-3H)bleomycin A2 on Saccharomyces cerevisiae cell walls and membranes. Antimicrob.Agents Chemother. 36, 2497-2505 (1992).
17. MOORE C.W.: Internucleosomal cleavage and chromosomal degradation by bleomycin and phleomycin in yeast. Cancer Res. 48, 6837-6843 (1988).
18. MÖSCH H.U., ROBERTS R.L., FINK G.R.: Ras2 signals via the Cdc42/Ste20/mitogen-activated protein kinase module to induce filamentous growth in Saccharomyces cerevisiae. Proc.Nat.Acad.Sci.USA 93, 5352-5356 (1996).
19. NITISS J., WANG J.C.: DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc.Nat.Acad.Sci.USA 85, 7501-7505 (1988).
20. OMURA S.: The Search for Bioactive Compounds from Microorganisms, pp. 37-38. Springer-Verlag, New York 1992.
21. PRATT W.B., RUDDON R.W., ENSMINGER W.D., MAYBAUM J.: The Anticancer Drugs, pp. 183-198 Oxford University Press, New York 1994.
22. QUINLAN R.A., POGSON C.I., GULL K.: The influence of the microtubule inhibitor methyl benzimidazol-2-yl-carbamate (MBC) on nuclear division and the cell cycle in Saccharomyces cerevisiae. J.Cell.Sci. 46, 341-352 (1980).
23. SIMON J.A., SZANKASI P., NGUYEN D.K., LUDLOW C., DUNSTAN H.M., ROBERTS C.J., JENSEN E.L., HARTWELL L.H., FRIEND S.U.: Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. Cancer Res. 60, 328-333 (2000).
24. STRATFORD M.: Another brick in the wall? Recent developments concerning the yeast cell envelope. Yeast 10, 1741-1752 (1994).
25. TILIGADA E., DELITHEOS A.: Involvement of potassium ions in the action of various antineoplastic drugs on the growth of Saccharomyces cerevisiae. Lett.Appl.Microbiol. 16, 251-253 (1993).
26. TILIGADA E., GIANNAKAKOU P., KARAVOKYROS I., DELlTHEOS A.: Effect of calcium channel blockers on the action of various anti-tumor agents in the yeast Saccharomyces cerevisiae. J.Appl.Bacteriol. 81, 481-485 (1996).
27. TILIGADA E., STAVRINIDIS E., DELITHEOS A.: Effect of tamoxifen in lower eukaryotic cells. Anticanc.Res. 17, 4098 (1997).
28. TILIGADA E., STAVRINIDIS E., MANOLIS C., DELITHEOS A.: Effect of chromatin function inhibitors on yeast whole cells and spheroplasts. Alternat.Lab.Anim. 27, 951-956 (1999).
29. WEISMAN L.S., BACALLAO R., WICKNER W.: Multiple methods for visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle. J.Cell Biol. 105, 1539-1547 (1987).
30. YANG S.S., YEH E., SALMON E.D., BLOOM K.: Identification of a mid-anaphase checkpoint in budding yeast. J.Cell Biol. 136, 345-354 (1997).